Company Email Format

Hopstem Biotechnology Co., Ltd.

Biotechnology Research United States 6 employees

Employees: 6
Contacts: 1
Emails: 1

hopstem.com LinkedIn Crunchbase

Hopstem Biotechnology Co., Ltd. Overview

Headquarters: United States
Phone Number: Available in AeroLeads
Website: hopstem.com
Industry: Biotechnology Research
Employees: 6
Founded: 2017
Funding: 40.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

human iPSCs human neural stem cells human progenitor cells human cortical neurons human dopamine neurons human astrocytes human motor neurons 3D brain organoids Transposon-based GFP dsRED line establishment Organ-on-chips human CNs differentiation kit

About Hopstem Biotechnology Co., Ltd.

Hopstem Bioengineering Co., Ltd. was founded on January 2017 in Hangzhou, by neuroscientists and stem cell biologists from Johns Hopkins University. Hopstem has established world-leading iPSCs platform of neural differentiation and cell engineering. Hopstem has developed several critical patented technologies，as well as CMC platform for iPSC-derived cell therapy products. Hopstem has iPSC reprogramming patent, GMP iPSC line with global licensing rights, iPSC-derived cell product manufacturing and quality system, and a variety of cell therapy products and pipelines, targeting CNS diseases, optical diseases and tumor. Hopstem’s first clinical product - neural progenitor cell hNPC01 targets neural injury diseases such as stroke and traumatic brain injury, has received China's IND approval and entered clinical trials. Hopstem is committed to translating the most cutting-edge technologies to provide global patients with safe, efficient and affordable cell therapy products.